Below you will find resources to help your patients manage out-of-pocket expenses for BANZEL®. Including information about Eisai Assistance Program and the Rx Outreach Patient Assistance Program.
The Eisai Assistance Program provides information to patients and healthcare professionals regarding the patient’s insurance benefits for coverage of BANZEL®. In addition, our agents can also provide information relating to payor-specific policies for the coverage of BANZEL®, information regarding billing and coding requirements, and answer questions regarding financial assistance options. Call the Eisai Assistance Program today for all of your billing, coding, coverage and financial assistance needs.
Eisai Assistance Program
Phone: 1-855-EISAI-4-U (1-855-347-2448)
Monday – Friday, 9 am to 5 pm ET
*Commercially insured patients pay the first $25 and Eisai Inc. will pay up to $50 per month. Most commercially insured patients will pay no more than $25 of their out-of-pocket expense. Maximum benefit paid by Eisai Inc. will be $50 per month. You could have additional financial responsibility depending on your insurance plan. Cash patients pay the first $25 and Eisai Inc. will pay up to $60 per month. For questions, please call 1-855-EISAI-4-U (1-855-347-2448).
Good toward the purchase of BANZEL® prescriptions. No substitutions permitted. Save this card to reuse with each prescription. Not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE. Offer available to MA residents through March 31, 2017. May not be combined with any other coupon, discount, prescription savings card, free trial, or other offer. Federal law prohibits the selling, purchasing, trading, or counterfeiting of this card. Such activities may result in imprisonment of 10 years, fines up to $25,000, or both. Void outside the USA and where prohibited by law. Eisai Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice. Patients and pharmacies are responsible for disclosing to insurance carriers the redemption and value of the card and complying with any other conditions imposed by insurance carriers on third-party payors. The value of this card is not contingent on any prior or future purchases. The card is solely intended to provide savings on any purchase of BANZEL®. Use of the card for any one purchase does not obligate the patient to make future purchases of BANZEL® or any other product. This offer will expire July 31, 2019.
Rx Outreach is a non-profit pharmacy making medications affordable for you and your family. The Rx Outreach Patient Assistance Program is for patients who are unable to afford their prescriptions and who meet specific financial and other eligibility criteria. Eisai has partnered with Rx Outreach to provide BANZEL® at low cost to financially needy patients who meet program eligibility criteria.
This includes patients who do not have insurance or other third-party payor prescription coverage, including Medicaid, Medicare, or managed care coverage.
For more information, including program eligibility requirements, please call 1-888-796-1234.
Hours: Monday-Friday, 7:00 AM-5:30 PM (Central Time).
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record
BANZEL® (rufinamide) is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults
For more information about BANZEL® please see Prescribing Information.
BANZEL® is available by prescription only.
This information is intended for use by our healthcare professionals in the United States only. Eisai Inc. recognizes the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here is not appropriate for use outside the United States.
This site contains information about products that may have different product labeling in different countries. This site is published by Eisai Inc.
BANZEL® is a registered trademark of Eisai R&D Management Co., Ltd., licensed to Eisai Inc.